In June 2011, the FDA released an announcement regarding the safety of the diabetes drug, Actos, and issued a warning to consumers of this drug. The FDA had been researching its link to bladder cancer and found that those people taking Actos for over a year were at an increased risk of developing bladder cancer. This warning came just a few days after both France and Germany took this pharmaceutical drug off the market completely.

The warning came as a result of an investigation the FDA conducted after hearing numerous instances of bladder cancer and tumors developing in patients taking Actos. In an ongoing study including over 193,000 participants of people with diabetes over the age of 40, the FDA discovered that those taking Actos for over a year are at a 40% higher increase for developing bladder cancer. It is alleged that the manufacturers of Actos, Takeda Pharmaceuticals, failed to adequately warn consumers of the link to bladder cancer and tumors, opening the door for possible lawsuits to ensue.

Actos has also already been linked to an increased risk of heart failure and stroke. Actos and drugs like Actos may trigger or worsen cardiac failure and other cardiac events in some patients. The high risk of not only having a heart attack but also developing bladder cancer has led the FDA to investigate carefully the complications currently associated with Actos.

Actos is a drug used to treat Type 2 diabetes by regulating the insulin levels. People with Type 2 diabetes are not able to produce enough insulin to efficiently manage the sugar levels in the blood. Actos acts to increase the sensitivity of body cells to insulin and prevent the levels of sugar in blood from rising to dangerous levels.

People across America are filing suit against Takeda Pharmaceuticals for complications arising after taking Actos. If you or someone you know has experienced either of these complications, you may be entitled to compensation for your medical bills or other damages. To discuss your legal options, contact the Actos litigation attorneys and Arias, Ozzello & Gignac today for a free consultation.